mdl 29311 has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dillberger, JE; Heineke, EW; Johnson, MB; Robinson, KM | 1 |
| Buzzetti, R; Chersi, A; Giovannini, C; Nisticò, L; Osborn, JF; Sorrentino, R | 1 |
2 other study(ies) available for mdl 29311 and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
Topics: Aging; Animals; Antioxidants; Atrophy; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred NOD; Mice, Inbred Strains; Pancreatic Diseases; Probucol | 1993 |
HLA-DQA1 and DQB1 gene polymorphisms in type I diabetic patients from central Italy and their use for risk prediction.
Topics: Adolescent; Alleles; Base Sequence; Diabetes Mellitus, Type 1; Female; HLA-DQ alpha-Chains; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Incidence; Italy; Male; Molecular Sequence Data; Odds Ratio; Polymorphism, Genetic; Predictive Value of Tests; Prevalence; Probucol; Risk | 1993 |